Exane Derivatives’s ProShares Short QQQ PSQ Stock Holding History

Exane Derivatives’s Portfolio PSQ Stock Details PSQ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-1,600	Closed	-$254K	–	722
2018 Q2	$254K	Buy	+1,600	New	+$261K	0.04%	238

Other funds holding PSQ

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

SG Americas Securities New York $92.9B AUM 36.98% 1-Year Est. Return

BCP

Berkeley Capital Partners Milton, Georgia $431M AUM 17.43% 1-Year Est. Return

Baird Financial Group Milwaukee, Wisconsin $64B AUM 22.64% 1-Year Est. Return

Ballew Advisors Jackson, Mississippi $194M AUM 20.37% 1-Year Est. Return

JWS

Juncture Wealth Strategies Scottsdale, Arizona $384M AUM 27.62% 1-Year Est. Return

LPL Financial San Diego, California $377B AUM 19.32% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Exane Derivatives's PSQ Position: Q3 2018 in Review

Exane Derivatives sold out of ProShares Short QQQ (PSQ) in Q3 2018, closing a stake of 1,600 shares — an estimated $254K sold.

Exane Derivatives first reported a position in PSQ in Q2 2018 and held it in 1 quarter. The position peaked at $254K in Q2 2018. 39 funds tracked by Wall St. Rank hold PSQ as of Q3 2018.

Exane Derivatives reported no remaining ProShares Short QQQ position as of Q3 2018 after selling out during the quarter.
Exane Derivatives sold 1,600 ProShares Short QQQ shares in Q3 2018, an estimated $254K.
Exane Derivatives first reported a position in ProShares Short QQQ in Q2 2018 and held it in 1 quarter.
Exane Derivatives's ProShares Short QQQ position peaked at $254K in Q2 2018.
39 funds tracked by Wall St. Rank held ProShares Short QQQ as of Q3 2018.

Based on Exane Derivatives's 13F filing for Q3 2018, filed 24 Oct 2018.